GT Biopharma, Inc. Intellectual Property Contracts & Agreements
18 Contracts & Agreements
- License Agreements (18 contracts)
- Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024 (Filed With SEC on August 14, 2024)
- Exclusive License Agreement with Regents of the University of Minnesota, dated March 26, 2021 (Filed With SEC on March 28, 2022)
- License Agreement with Daniel A. Vallera, Ph.D (Filed With SEC on August 11, 2017)
- License Agreement with the University of Minnesota (Filed With SEC on August 11, 2017)
- License Agreement with MultiCell Immunotherapeutics, Inc (Filed With SEC on August 11, 2017)
- License Agreement with ID4 Pharma LLC (Filed With SEC on August 11, 2017)
- LICENSE AGREEMENT (Filed With SEC on January 24, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on January 24, 2017)
- LICENSE AGREEMENT (Filed With SEC on December 28, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 31, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 31, 2016)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on October 31, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 31, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 3, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 3, 2016)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on October 3, 2016)
- LICENSE AGREEMENT (Filed With SEC on October 3, 2016)
- AMENDMENT #2 TO EXCLUSIVE LICENSE AND SUPPLY AGREEMENT (Filed With SEC on July 26, 2006)
